GCG and Hypoglycemia: Indeed, several clinical trials and meta-analyses[16–21] for GLP-1 RAs have demonstrated the lowering effect of glycemic levels as well as raised hypoglycemia and treatment discontinuation, although the mechanisms are not very clearly understood.